This topic contains a solution. Click here to go to the answer

Author Question: The nitroblue tetrazolium test is used to diagnose: a. Chronic granulomatous disease b. ... (Read 106 times)

P68T

  • Hero Member
  • *****
  • Posts: 509
The nitroblue tetrazolium test is used to diagnose:
 
  a. Chronic granulomatous disease
  b. Pelger-Hut anomaly
  c. May-Hegglin anomaly
  d. Necrobiosis

Question 2

Nonmalignant disorders of leukocytes are:
 
  a. Inherited and cause no symptoms
  b. Acquired and cause serious disease
  c. Acquired and affect the nuclei of cells
  d. Acquired or inherited and range from benign to life threatening



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

diana chang

  • Sr. Member
  • ****
  • Posts: 288
Answer to Question 1

ANS: A
The nitroblue tetrazolium test is useful for the diagnosis of chronic granulomatous disease.

Answer to Question 2

ANS: D
Benign (nonmalignant) disorders of leukocytes are inherited or acquired alterations that do not possess the characteristics of dysplasia or malignancy. Many are asymptomatic, whereas others are life threatening.




P68T

  • Member
  • Posts: 509
Reply 2 on: Jun 25, 2018
Great answer, keep it coming :)


bimper21

  • Member
  • Posts: 309
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

For a complete list of videos, visit our video library